Geller Matthew 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 24, 2009
Insider Transaction Report
Form 4
Geller Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2009-09-22+15,000→ 45,000 totalExercise: $30.79Exp: 2019-09-21→ Common Stock, $.001 par value (15,000 underlying)
Footnotes (1)
- [F1]The option vests monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested.